Femcon Fe (Norethindrone and Ethinyl Estradiol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 12, 2018 Category: Drugs & Pharmacology Source Type: news

Imvexxy (Estradiol Vaginal Inserts) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 27, 2018 Category: Drugs & Pharmacology Source Type: news

Norethindrone and Ethinyl Estradiol Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - June 20, 2018 Category: Drugs & Pharmacology Source Type: news

New study suggests ovarian hormone may make drug withdrawal symptoms worse for women
(Dickinson College) Researchers found that a form of the estrogen hormone can contribute to drug relapse in females by worsening withdrawal symptoms. The study looked at the interaction of the female sex hormone estradiol and methamphetamine. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 18, 2018 Category: International Medicine & Public Health Source Type: news

Testosterone May Be Key to CVD Risk in Women Testosterone May Be Key to CVD Risk in Women
A new analysis shows that higher testosterone levels and a higher ratio of testosterone to estradiol in postmenopausal women are associated with higher risk for cardiovascular disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Does stabilizing female hormones help lower suicide risk?
(University of Illinois at Chicago) A three-year, $750,000 grant from the National Institutes of Mental Health will help researchers determine whether the stabilization of ovarian hormones estradiol and progesterone can help lower symptoms associated with suicidality among females at risk for suicide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2018 Category: International Medicine & Public Health Source Type: news

Oral Semaglutide Success; Lowest-Dose Vaginal Estradiol OK'd
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 1, 2018 Category: Urology & Nephrology Source Type: news

Postmenopausal Sex Hormone Levels Associated With Later CVD
FRIDAY, June 1, 2018 -- In postmenopausal women, higher testosterone/estradiol ratios are associated with increased risks for incident cardiovascular disease (CVD), coronary heart disease (CHD), and heart failure events, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Imvexxy for Moderate to Severe Dyspareunia FDA Approves Imvexxy for Moderate to Severe Dyspareunia
The FDA approved estradiol vaginal inserts (Imvexxy, TherapeuticsMD) for moderate to severe dyspareunia.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 31, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news

Hormone therapy may slow cognitive decline
A combination therapy of estradiol and progesterone may benefit cognitive function in postmenopausal women, a study inMenopause suggests.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 31, 2018 Category: Endocrinology Source Type: news

TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause
BOCA RATON, Fla., May 30, 2018 /PRNewswire/ -- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved Imvexxy (estradiol vaginal inserts)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 31, 2018 Category: Drugs & Pharmacology Source Type: news

On second try, TherapeuticsMD lands FDA nod for vaginal capsule
TherapeuticsMD (NSDQ:TXMD) said today that it won FDA approval for its applicator-free estradiol vaginal capsule, TX-004HR. The soft-gel capsule is designed to treat moderate-to-severe vaginal pain experienced during sex, a symptom of vulvar and vaginal atrophy in women who have undergone menopause. Get the full story at our sister site, Drug Delivery Business News. The post On second try, TherapeuticsMD lands FDA nod for vaginal capsule appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 30, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat Women's Health TherapeuticsMD Source Type: news

Hormone Levels After Menopause Tied to Heart Risks (CME/CE)
(MedPage Today) -- Higher testosterone/estradiol ratio associated with CVD, CHD, and HF (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 29, 2018 Category: Endocrinology Source Type: news

Allergan Issues Nationwide Voluntary Recall of TAYTULLA ® Softgel Capsules 1mg/20mcg Sample Packs Due to Out of Sequence Capsules
Allergan plc (NYSE:AGN) today issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA ® (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6x28 physicians sample pack, indicated for use by women to prevent pregnancy. Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample p ack of TAYTULLA. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules. (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 29, 2018 Category: Food Science Source Type: news

Allergan Issues Nationwide Voluntary Recall of TAYTULLA ® Softgel Capsules 1mg/20mcg Sample Packs Due to Out of Sequence Capsules
Allergan plc (NYSE:AGN) today issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA ® (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6x28 physicians sample pack, indicated for use by women to prevent pregnancy. Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of TAYTULLA. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules. (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 29, 2018 Category: Food Science Source Type: news

Osteoporosis Spinal Fractures; Vaginal Estradiol Tx; Diabetic Dog Lawsuit?
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - May 11, 2018 Category: OBGYN Source Type: news

Low - Dose Vaginal Estradiol Improves Menopause - Linked QOL
Significant improvement in total MENQOL scores, MENQOL sexual function domain for vaginal estradiol (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 10, 2018 Category: Psychiatry Tags: Family Medicine, Gynecology, Internal Medicine, Pharmacy, Psychiatry, Journal, Source Type: news

Low-Dose Vaginal Estradiol Improves Menopause-Linked QOL
THURSDAY, May 10, 2018 -- For menopausal women with moderate-severe vulvovaginal symptoms, treatment with low-dose vaginal estradiol is associated with improved menopause-related quality of life, according to a study published online May 7 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 10, 2018 Category: Pharmaceuticals Source Type: news

Vaginal estradiol tablets outperform moisturizers when treating vulvovaginal problems
(The North American Menopause Society (NAMS)) Sex shouldn't hurt at any age, yet 75 percent of postmenopausal women report vaginal dryness, and up to 40 percent report pain with intercourse. A new study reports that vaginal estradiol tablets just might be what's needed to relieve vulvovaginal problems and improve overall quality of life. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2018 Category: International Medicine & Public Health Source Type: news

Lo-Zumandimine (Drospirenone and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 19, 2018 Category: Drugs & Pharmacology Source Type: news

TherapeuticsMD negotiates label for vaginal capsule after NDA resubmission
TherapeuticsMD (NSDQ:TXMD) is negotiating with the FDA over the proposed label for its investigational, applicator-free estradiol vaginal capsule, TX-004HR, the company reported today. The softgel capsule is designed to treat moderate-to-severe vaginal pain experienced during sex, a symptom of vulvar and vaginal atrophy in women who have undergone menopause. Get the full story at our sister site, Drug Delivery Business News. The post TherapeuticsMD negotiates label for vaginal capsule after NDA resubmission appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - April 11, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat Women's Health TherapeuticsMD Source Type: news

Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
BRIDGEWATER, N.J., April 6, 2018 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has launched a generic version of Estrace® Cream (estradiol vaginal cream, US... Biopharmaceuticals, Generic, Product Launch Impax Laboratories, Perrigo Company, Estrace Cream, estradiol vaginal cream (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2018 Category: Pharmaceuticals Source Type: news

Vaginal Estradiol Offers Little Help for Postmenopausal Symptoms
(MedPage Today) -- Moisturizer no better than placebo gel, either (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - March 19, 2018 Category: OBGYN Source Type: news

First Documented Case of Transgender Woman Breastfeeding First Documented Case of Transgender Woman Breastfeeding
A transgender woman has fed her infant solely with breast milk for the first 6 weeks, after treatment with domperidone, estradiol, progesterone, and breast pumping.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 20, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Estradiol Therapy Mitigates Effects of Stress on Memory Estradiol Therapy Mitigates Effects of Stress on Memory
A new study examines how postmenopausal estradiol therapy may impact the effects of stress on cognition.Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 16, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Balcoltra (Levonorgestrel and Ethinyl Estradiol and Ferrous Bisglycinate Tablets ) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 7, 2018 Category: Drugs & Pharmacology Source Type: news

Kalliga (Desogestrel And Ethinyl Estradiol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 31, 2018 Category: Drugs & Pharmacology Source Type: news

Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream
DUBLIN, Jan. 24, 2018 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for the generic version of Estrace® Cream (estradiol va... Biopharmaceuticals, Generics, FDA Perrigo, Estrace, estradiol (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 24, 2018 Category: Pharmaceuticals Source Type: news

Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate (LOESTRIN Fe) Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 18, 2018 Category: Drugs & Pharmacology Source Type: news

Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
ATLANTA, Jan. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Avion Pharmaceuticals, LLC, the makers of the Prenate® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral contraceptive Balcoltra... Biopharmaceuticals, FDA Avion Pharmaceuticals, Balcoltra, levonorgestrel, ethinyl estradiol (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2018 Category: Pharmaceuticals Source Type: news

Avion Pharmaceuticals Announces FDA Approval of Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) Oral Contraceptive
ATLANTA, Jan. 17, 2018 /PRNewswire/ -- Avion Pharmaceuticals, LLC, the makers of the Prenate ® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral contraceptive Balcoltra (levonorgestrel and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 17, 2018 Category: Drugs & Pharmacology Source Type: news

Desogen (Desogestrel and Ethinyl Estradiol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 16, 2018 Category: Drugs & Pharmacology Source Type: news

Femhrt (Norethindrone Acetate, Ethinyl Estradiol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 12, 2018 Category: Drugs & Pharmacology Source Type: news

Estrasorb (Estradiol Topical Emulsion) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 12, 2018 Category: Drugs & Pharmacology Source Type: news

Cryselle (Norgestrel and Ethinyl Estradiol) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2018 Category: Drugs & Pharmacology Source Type: news

Norminest Fe and Norquest Fe (Norgestrel and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2018 Category: Drugs & Pharmacology Source Type: news

Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace(R) Cream
Mylan now offers estradiol in four delivery methods The approval showcases Mylan's ongoing investment in complex products HERTFORDSHIRE, England and PITTSBURGH, Dec. 29, 2017 -- (Healthcare Sales & Marketing Network) -- Global pharmaceutical leader ... Biopharmaceuticals, Generics, FDA, Product Launch Mylan, Estradiol Vaginal Cream, Estrace (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 29, 2017 Category: Pharmaceuticals Source Type: news

TherapeuticsMD submits NDA for hormone therapy to treat vasomotor symptoms
TherapeuticsMD (NSDQ:TXMD) has submitted its bio-identical hormone therapy to the FDA for approval as a treatment for moderate-to-severe vasomotor symptoms due to menopause. The company’s investigational combination of estradiol and progesterone is delivered in a single, oral soft-gel capsule. Get the full story at our sister site, Drug Delivery Business News. The post TherapeuticsMD submits NDA for hormone therapy to treat vasomotor symptoms appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 29, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Gynecological Pharmaceuticals Wall Street Beat Women's Health TherapeuticsMD Source Type: news

Mimvey (Estradiol and Norethindrone Acetate Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 29, 2017 Category: Drugs & Pharmacology Source Type: news

Rapid effects of estradiol on aggression depend on genotype in a species with an estrogen receptor polymorphism - Merritt J, Davis M, Jalabert C, Libecap T, Williams D, Soma K, Maney D.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - December 28, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

TherapeuticsMD shares tumble after FDA pushes NDA decision to mid ’ 18
TherapeuticsMD (NSDQ:TXMD) shares fell -7% yesterday after the company announced that the FDA accepted its resubmitted application for TX-004HR, an investigational, applicator-free estradiol vaginal soft-gel capsule for the treatment of dyspareunia. The company’s shares took a hit presumably because it revealed that its resubmitted application is a Class 2 response – a Class 1 response would have quickened the timeline for potential approval. As a Class 2 response, the FDA is slated to make a decision in six months. Get the full story at our sister site, Drug Delivery Business News. The post TherapeuticsMD...
Source: Mass Device - December 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Gynecological Pharmaceuticals Regulatory/Compliance Wall Street Beat Women's Health TherapeuticsMD Source Type: news

Balziva (Ethinyl Estradiol and Norethindrone Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 13, 2017 Category: Drugs & Pharmacology Source Type: news

Norethindrone and Ethinyl Estradiol Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - December 6, 2017 Category: Drugs & Pharmacology Source Type: news

Balziva (Ethinyl Estradiol and Norethindrone Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 6, 2017 Category: Drugs & Pharmacology Source Type: news

Seasonique (Levonorgestrel, Ethinyl Estradiol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 5, 2017 Category: Drugs & Pharmacology Source Type: news

Brevicon (Norethindrone and Ethinyl Estradiol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 15, 2017 Category: Drugs & Pharmacology Source Type: news

Angeliq (Drospirenone and Estradiol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 14, 2017 Category: Drugs & Pharmacology Source Type: news

CombiPatch (Estradiol, Norethindrone Acetate Transdermal System) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 14, 2017 Category: Drugs & Pharmacology Source Type: news

Delestrogen (Estradiol valerate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2017 Category: Drugs & Pharmacology Source Type: news

Brevicon (Norethindrone and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 20, 2017 Category: Drugs & Pharmacology Source Type: news